// App-Quantinova.ai

4442 : Very low methylation is a novel epigenetic regulatory mechanism in normal tissues and predisposes to hypermethylation in cancer

Researchers

Presenter

  • priyanka madireddi

Principal Investigators

  • Jaroslav Jelinek

  • Justin Lee

  • Takahiro Sato

  • Jean-Pierre Issa

Medical Centers

  • Temple University Medical School, Philadelphia, PA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Alpha-thalassemia myelodysplasia syndrome

  • Solid malignancies

Biomarkers

  • Methyl-CpG binding domain protein 4

  • DNA methylation

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved